Jenscare Scientific Co., Ltd. released its monthly return for June 2026, confirming that both authorised and issued share capital remained unchanged during the period.

Total authorised/registered share capital stands at 417.17 million shares with a par value of RMB 1 each. This is split between 310.31 million H-shares listed on the Hong Kong Stock Exchange and 106.86 million unlisted domestic and foreign shares.

Issued share capital mirrors the authorised structure: 310.31 million listed H-shares and 106.86 million unlisted shares. No treasury shares were held, issued, or cancelled, and the company executed no share repurchases, options, warrants, or convertible instruments in the month.

Jenscare confirmed that, as of 30 June 2026, it continued to meet the HKEX minimum public-float requirement of 17.32% for its H-shares.